title: Influence of tobacco smoke on the pharmacokinetics of citalopram and its enantiomers.
abstract: The purpose of this study was to evaluate the influence of tobacco smoke on the pharmacokinetics of citalopram (CIT) and desmethylcitalopram (DCIT) and its enantiomers on an animal model. High performance liquid chromatography (HPLC) with a diode array detector (DAD) was used for the identification and quantification of the studied compounds. The HPLC quantification of racemic mixtures of CIT was performed on a C18 column. The limits of detection (LOD) and quantification (LOQ) were: 7 and 10 ng/ml respectively. HPLC separation of citalopram enantiomers (S- and R-CIT) was performed on a Chirobiotic V column. The limits of detection (LOD) and quantification (LOQ) were: 6 and 15 ng/ml for R- and S-CIT respectively. The experiment was carried out on male Wistar rats. The rats were exposed to tobacco smoke for five days (6 hours per day). After the exposure, citalopram was administered in a dose of 10 mg/kg intragastrically. In the control group (non-exposed animals), citalopram was administered in the same way and at an equal dose. The blood of the animals was collected at nine time points. It was found that tobacco smoke exposure inhibits the biotransformation of citalopram. The half-life of the racemic mixture of citalopram after intragastric administration was increased by about 287%. Changes in the pharmacokinetic parameters of S-citalopram (active isomer) show a similar tendency to those of the racemic mixture. The pharmacokinetics of R-citalopram showed no statistically important differences after tobacco smoke exposure. Alterations in the pharmacological parameters of desmethylcitalopram presented an opposite trend to the parent drug. After exposure to tobacco smoke, the induction of metabolism of this compound was observed.
authors.affiliation: Department of Analytical Chemistry, Jagiellonian University, Cracow, Poland.
authors.forename: J
authors.initials: J
authors.lastname: Majcherczyk
authors.forename: M
authors.initials: M
authors.lastname: Kulza
authors.forename: M
authors.initials: M
authors.lastname: Senczuk-Przybylowska
authors.forename: E
authors.initials: E
authors.lastname: Florek
authors.forename: W
authors.initials: W
authors.lastname: Jawien
authors.forename: W
authors.initials: W
authors.lastname: Piekoszewski
mesh_terms: D000818:Animals; D001711:Biotransformation; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D015283:Citalopram / Q000031:analogs & derivatives* / Q000493:pharmacokinetics*; D006207:Half-Life; D057230:Limit of Detection; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D013237:Stereoisomerism; D014028:Tobacco Smoke Pollution / Q000009:adverse effects*
chemical_list: D014028:Tobacco Smoke Pollution; D015283:Citalopram; C046304:desmethylcitalopram